Quantinuum Inc. (QNT)
SEC filings, insider trading & institutional ownership from EDGAR.
Quantinuum is a full-stack quantum computing company that builds quantum hardware, middleware and application software to make quantum computing deployable in real-world environments. It was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, and it remains a controlled affiliate of Honeywell. The company believes computing will become hybrid, combining CPUs, GPUs and quantum processors, and it designs its systems for hybrid quantum-classical workflows, including quantum-enabled AI in which quantum-generated data is used to train and guide AI models. It is in the early stages of commercial growth: net revenue was $30.9 million and net loss $192.6 million for 2025, with bookings of $79.3 million, and cash and cash equivalents were $677.0 million at March 31, 2026.
The platform offers hardware platforms, developer tools, application libraries and solution-targeted intellectual property. Its hardware uses the trapped-ion QCCD architecture, in which electromagnetic fields suspend and move identical qubits and lasers control them. The company has commercially deployed three system generations: H1 (2020), H2 (2023) and Helios (2025). Helios has 98 physical qubits, 99.921% average two-qubit gate fidelity and 48 logical qubits. Future systems are Sol, expected in 2027 with up to about 100 logical qubits, and Apollo, expected in 2029 with hundreds of logical qubits. Quantinuum was selected for Stage B of DARPA's Quantum Benchmarking Initiative. On the software side, it offers middleware, compilers, algorithm libraries and application frameworks, including the Python-like quantum programming language Guppy and a real-time control engine. The software is designed to work across multiple quantum hardware platforms and is compatible with ecosystems such as NVIDIA CUDA-Q. The company keeps core architectural and system-level IP proprietary and licenses some software as open-source to encourage developer adoption.
Customer engagements focus on pharmaceuticals, materials science, financial services, government and industrial markets. Named customers and innovation partners include JPMorgan Chase in financial services, Amgen in pharmaceuticals, Mitsui & Co. in cybersecurity and Honeywell in chemistry. Honeywell is also an early customer and testing ground and has said it intends to remain a strategic customer and partner. Its monetization strategy is to lead in on-premises and cloud-based quantum solutions, then expand into higher-margin software, applications and outcome-driven IP. The company cites industry forecasts of substantial end-user value from quantum computing by 2030 and 2040, concentrated in chemistry, materials, life sciences, finance, logistics and cryptography.
Quantinuum has about 700 employees as of March 11, 2026, including roughly 410 hardware experts and 105 software experts, and more than 450 hold PhDs or Master's degrees. It has invested more than $2 billion in R&D over the last decade. It benefits from Honeywell's infrastructure, supply-chain relationships and management expertise. It competes with other quantum approaches, such as superconducting architectures, which may offer faster gate speeds but often need more operations and error-correction overhead. The text does not state its headquarters location.
AI-summarized from the Business section of the company’s IPO prospectus.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
| Form | Filed | Accession |
|---|---|---|
| 8-K | Nov 5, 2026 | 0001628280-26-071000EDGAR |
| SC 13G/AamendedBlackRock Portfolio Management LLC | Oct 27, 2026 | 0002052113-26-001105EDGAR |
| SC 13GKenneth Griffin and 6 other reporting persons | Oct 6, 2026 | 0001104659-26-114121EDGAR |
| 8-K | Sep 8, 2026 | 0001628280-26-060934EDGAR |
| SC 13GHoneywell International Inc. and 1 other reporting person | Aug 13, 2026 | 0001493152-26-037881EDGAR |
| 10-Q | Aug 13, 2026 | 0001628280-26-056743EDGAR |
| SC 13GCapital Research Global Investors | Aug 12, 2026 | 0001422848-26-000109EDGAR |
| 8-K | Aug 11, 2026 | 0001628280-26-055699EDGAR |
Insider trading
From Form 4 filings
| Insider | Date | Type |
|---|---|---|
| Schulman Robin | Jul 17, 2026 | Grant / award |
| BHATIA MANISH H | Jun 5, 2026 | Buy |
| DENMAN KENNETH D | Jun 5, 2026 | Buy |
| Daugherty Paul R. | Jun 5, 2026 | Buy |
| Dehoff Kevin Scott | Jun 5, 2026 | Buy |
Top holders
13F & 13D/G • latest quarter
| Holder | Stake | Filed | Value |
|---|---|---|---|
| Capital World Investors | 12.4% | Aug 12, 2026 | $372.65M |
| CITADEL ADVISORS LLC | 6.6% | Sep 1, 2026 | $199.08M |
| BlackRock, Inc. | 6.1% | Aug 7, 2026 | $184.68M |
| Capital Research Global Investors | 4.8% | Aug 12, 2026 | $143.4M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.1% | Aug 14, 2026 | $92.42M |
QNT's filings are public. The insight is one click away.
Scrutar's AI reads every QNT filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a QNT filing.
Get an email when QNT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.